- Previous Close
0.0150 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0150 - 0.0150 - 52 Week Range
0.0050 - 0.0650 - Volume
0 - Avg. Volume
16,159 - Market Cap (intraday)
1.791M - Beta (5Y Monthly) -0.01
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1300 - Earnings Date Mar 31, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
RAMM Pharma Corp. engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland. It offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products, as well as resells medical supplies products; and sells medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
www.wearerammpharma.com--
Full Time Employees
October 31
Fiscal Year Ends
Sector
Recent News: RAMM.CN
View MorePerformance Overview: RAMM.CN
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RAMM.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RAMM.CN
View MoreValuation Measures
Market Cap
1.79M
Enterprise Value
1.51M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.41
Price/Book (mrq)
0.14
Enterprise Value/Revenue
0.34
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-23.67%
Return on Equity (ttm)
-75.84%
Revenue (ttm)
4.4M
Net Income Avi to Common (ttm)
-15.23M
Diluted EPS (ttm)
-0.1300
Balance Sheet and Cash Flow
Total Cash (mrq)
480.44k
Total Debt/Equity (mrq)
1.59%
Levered Free Cash Flow (ttm)
-2.21M